Comparison of staging MRI to re-resection for localised bladder cancer: Narrative review.
Hugo KlempfnerPaul AndersonPublished in: BJUI compass (2024)
VI-RADS scoring could revolutionise BCa staging, especially regarding re-TURBT. There is potential that VI-RADS correlates more with the histopathology of re-TURBT and radical cystectomy than initial TURBT. While promising, ongoing research is essential to validate utility, refine selection criteria, and address economic considerations. Integration of VI-RADS into BCa staging holds potential benefits for patients and health care systems.
Keyphrases
- lymph node
- end stage renal disease
- healthcare
- pet ct
- ejection fraction
- newly diagnosed
- chronic kidney disease
- magnetic resonance imaging
- peritoneal dialysis
- prognostic factors
- human health
- contrast enhanced
- diffusion weighted imaging
- health insurance
- climate change
- health information
- muscle invasive bladder cancer
- affordable care act